Skip to main content
TipRanks
Go Ultimate75% OFF

Bayer Cropscience India Limited (BAYERCROP) AI Stock Analysis

5 Followers
IN:BAYERCROP

Bayer Cropscience India Limited

(NSE:BAYERCROP)

Select Model
Rating:78Outperform
Price Target:INR 3,927.00â–²(14.01% Upside)
Action:reiterated
Date:08/28/26

The overall score is driven primarily by Bayer CropScience India’s high‑quality financial profile, combining strong growth, solid margins, and a very conservative balance sheet, which together support a lower‑risk earnings base. Valuation is supportive but not deeply discounted, with a mid‑range P/E offset by an attractive dividend yield, making the stock reasonably priced for its fundamentals. Technicals currently show a mild downtrend and subdued momentum, which slightly tempers the otherwise strong fundamental and valuation picture.

Positive Factors
Very low leverageThe exceptionally low-debt balance sheet limits financing strain and preserves flexibility during weaker agricultural cycles. Rising equity provides an additional capital buffer, allowing the company to support operations and pursue growth without relying heavily on external borrowing.
Negative Factors
Margin compressionLower margins than in FY2023–FY2024 indicate that revenue growth has not translated consistently into prior levels of profitability. Persistent margin pressure could reduce earnings scalability and leave less operating cash available for reinvestment, shareholder returns, or resilience during softer demand.

Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%IN:BAYERCROP-21.29%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 155.05B
Dividend Yield
4.35%
Average Volume (3M)
3,961
Price to Earnings (P/E)
20.8
Beta (1Y)
0.83
Revenue Growth
-5.00%
EPS Growth
22.45%
Country
India
Employees
1,317
Sector
General
Sector Strength
55
Industry
Agricultural Inputs

Bayer Cropscience India Limited Business Overview & Revenue Model

Company Description

Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, among...

Bayer Cropscience India Limited Financial Statement Overview

Summary

Financial performance is very strong, driven by robust profitability, healthy double‑digit margins, and a conservative balance sheet with low debt, offset only by some margin pressure and volatile but generally solid cash generation.

Income Statement

86Very Positive

Balance Sheet

92Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue52.93B56.75B54.73B51.06B51.40B47.34B
Gross Profit20.93B17.65B20.59B21.81B23.09B20.57B
EBITDA10.57B9.69B6.92B9.79B9.27B8.15B
Net Income7.46B6.89B5.68B7.41B7.58B6.45B
Balance Sheet
Total Assets55.37B56.99B52.46B45.97B46.79B43.53B
Cash, Cash Equivalents and Short-Term Investments5.42B14.79B9.29B12.11B9.02B8.19B
Total Debt704.00M818.00M1.05B471.00M735.00M864.00M
Total Liabilities23.53B27.34B23.95B17.48B19.66B18.29B
Stockholders Equity31.84B29.66B28.50B28.49B27.12B25.24B
Cash Flow
Free Cash Flow010.57B2.59B9.06B5.32B1.60B
Operating Cash Flow010.97B3.00B9.52B6.09B2.15B
Investing Cash Flow0414.00M389.00M4.00M833.00M642.00M
Financing Cash Flow0-6.12B-6.10B-6.56B-6.13B-7.03B

Bayer Cropscience India Limited Technical Analysis

Technical Analysis SentimentNeutral
Last Price3444.50

Price Trends

50DMA3525.33Negative
100DMA3772.43Negative
200DMA4076.89Negative

Market Momentum

MACD-31.57Negative
RSI54.65Neutral
STOCH63.29Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Neutral. The current price of 3444.50 is above the 20-day moving average (MA) of 3318.73, below the 50-day MA of 3525.33, and below the 200-day MA of 4076.89, indicating a neutral trend. The MACD of -31.57 indicates Negative momentum. The RSI at 54.65 is Neutral, neither overbought nor oversold. The STOCH value of 63.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:BAYERCROP.

Bayer Cropscience India Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:BAYERCROP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:BAYERCROPIN:BAYERCROP78OutperformINR 154.80B20.80―4.35%-5.00%22.45%
IN:DHANUKAIN:DHANUKA73OutperformINR 40.27B14.51―0.22%-0.06%0.75%
IN:SHARDACROPIN:SHARDACROP71OutperformINR 65.69B10.24―2.06%17.28%42.45%
IN:RALLISIN:RALLIS63NeutralINR 36.79B18.72―1.59%6.82%11.93%
IN:PIINDIN:PIIND58NeutralINR 260.17B29.63―0.58%-14.95%-41.96%
IN:UPLIN:UPL58NeutralINR 468.51B25.01―1.08%10.33%-14.32%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-50%-25%0%25%50%IN:BAYERCROPIN:DHANUKAIN:PIINDIN:RALLISIN:SHARDACROPIN:UPLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:BAYERCROP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:BAYERCROPBayer Cropscience India Limited3444.50-938.79-21.42%
IN:DHANUKADhanuka Agritech Limited903.45-365.10-28.78%
IN:PIINDPI Industries Limited1714.80-1809.19-51.34%
IN:RALLISRallis India Limited189.20-57.98-23.46%
IN:SHARDACROPSharda Cropchem Ltd.728.15-53.22-6.81%
IN:UPLUPL Limited555.00-210.39-27.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 28, 2026